The prolonged presence of CTLs inside the tumour for the anti-CD137 treated group due to delayed apoptosis is in agreement with reports of anti-apoptotic effects of CD137 signalling on activated T cells [38,39]. This evidence concerns the gene TNFRSF9 and neoplasm.